Business Description
Acadia Healthcare Co Inc
NAICS : 622110
SIC : 8062
ISIN : US00404A1097
Compare
Compare
Traded in other countries / regions
ACHC.USA7RA.GermanyACHC.Mexico IPO Date
2014-03-04Description
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities in the United States, United Kingdom, and Puerto Rico. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The U.S. facilities receive the major proportion of payments from Medicaid, with the second-largest proportion from commercial payors. In the United Kingdom, the majority of Acadia's revenue comes from its healthcare facilities, and virtually all of the payment received is from the National Health Service.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | 0.52 | |||||
| Debt-to-Equity | 0.66 | |||||
| Debt-to-EBITDA | 3.16 | |||||
| Interest Coverage | 5.11 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.74 | |||||
| Beneish M-Score | -2.37 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.9 | |||||
| 3-Year EBITDA Growth Rate | -25 | |||||
| 3-Year EPS without NRI Growth Rate | 16.9 | |||||
| 3-Year FCF Growth Rate | -55.9 | |||||
| 3-Year Book Growth Rate | 12.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 11.1 | |||||
| Future 3-5Y Total Revenue Growth Rate | 9.02 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 69.62 | |||||
| 9-Day RSI | 50.21 | |||||
| 14-Day RSI | 40.78 | |||||
| 6-1 Month Momentum % | -17.95 | |||||
| 12-1 Month Momentum % | -28.36 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | |||||
| Quick Ratio | 1.06 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 18.46 | |||||
| Days Sales Outstanding | 44.04 | |||||
| Days Payable | 542.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.2 | |||||
| Shareholder Yield % | -8.76 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 96.45 | |||||
| Operating Margin % | 17.48 | |||||
| Net Margin % | 8.99 | |||||
| FCF Margin % | -15.93 | |||||
| ROE % | 9.78 | |||||
| ROA % | 5.05 | |||||
| ROIC % | 8.25 | |||||
| ROC (Joel Greenblatt) % | 19.42 | |||||
| ROCE % | 10.06 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.45 | |||||
| Forward PE Ratio | 10.93 | |||||
| PE Ratio without NRI | 11.7 | |||||
| Shiller PE Ratio | 120.9 | |||||
| PS Ratio | 1.21 | |||||
| PB Ratio | 1.24 | |||||
| Price-to-Tangible-Book | 5.54 | |||||
| Price-to-Operating-Cash-Flow | 29.06 | |||||
| EV-to-EBIT | 11.69 | |||||
| EV-to-Forward-EBIT | 9.22 | |||||
| EV-to-EBITDA | 9.02 | |||||
| EV-to-Forward-EBITDA | 7.28 | |||||
| EV-to-Revenue | 1.84 | |||||
| EV-to-Forward-Revenue | 1.66 | |||||
| EV-to-FCF | -11.56 | |||||
| Price-to-Projected-FCF | 1.26 | |||||
| Price-to-Median-PS-Value | 0.57 | |||||
| Price-to-Graham-Number | 1.72 | |||||
| Earnings Yield (Greenblatt) % | 8.55 | |||||
| FCF Yield % | -13 | |||||
| Forward Rate of Return (Yacktman) % | 0.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Acadia Healthcare Co Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 2,862.162 | ||
| EPS (TTM) (€) | 2.799 | ||
| Beta | 0.29 | ||
| Volatility % | 43.87 | ||
| 14-Day RSI | 40.78 | ||
| 14-Day ATR (€) | 1.107386 | ||
| 20-Day SMA (€) | 37.77 | ||
| 12-1 Month Momentum % | -28.36 | ||
| 52-Week Range (€) | 34.2 - 80.5 | ||
| Shares Outstanding (Mil) | 92.89 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Acadia Healthcare Co Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Acadia Healthcare Co Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Acadia Healthcare Co Inc Frequently Asked Questions
What is Acadia Healthcare Co Inc(FRA:7RA)'s stock price today?
The current price of FRA:7RA is €38.20. The 52 week high of FRA:7RA is €80.50 and 52 week low is €34.20.
When is next earnings date of Acadia Healthcare Co Inc(FRA:7RA)?
The next earnings date of Acadia Healthcare Co Inc(FRA:7RA) is 2025-02-27 Est..
Does Acadia Healthcare Co Inc(FRA:7RA) pay dividends? If so, how much?
Acadia Healthcare Co Inc(FRA:7RA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers